21:56:05 EDT Thu 30 Jul 2026
Enter Symbol
or Name
USA
CA



Dolby Laboratories Reports Third Quarter 2026 Financial Results

2026-07-30 16:15 ET - News Release

Dolby Laboratories Reports Third Quarter 2026 Financial Results

PR Newswire

SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026.

"We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories. "We are expanding our total addressable market and creating new opportunities with content partners through the Video Distribution Program and Dolby OptiView, and we continue to bring Dolby Atmos and Dolby Vision to more experiences from live sports, to music in the car, to user-generated content on mobile devices and more."

Third Quarter Fiscal 2026 Financial Highlights

  • Total revenue was $305 million, compared to $316 million for the third quarter of fiscal 2025.
  • GAAP net income was $29 million or $0.30 per diluted share, compared to GAAP net income of $46 million or $0.48 per diluted share for the third quarter of fiscal 2025. On a non-GAAP basis, third quarter net income was $65 million or $0.69 per diluted share, compared to $76 million or $0.78 per diluted share for the third quarter of fiscal 2025.
  • Dolby repurchased 1.2 million shares of its common stock for approximately $65 million.

A complete listing of Dolby's non-GAAP measures is described and reconciled to the corresponding GAAP measures at the end of this release.

Recent Business Highlights

  • The 2026 FIFA World Cup was shown in Dolby Atmos and/or Dolby Vision across broadcast, streaming, and pay TV, including Peacock and Comcast in the U.S., Bell TV in Canada, and TV GLOBAL in Brazil.
  • On TVs, Dolby Vision 2 is now in market with some Hisense TVs, and by the end of this calendar year, TCL and Philips will also be shipping TVs with Dolby Vision 2.
  • RayNeo, the leading provider of augmented reality glasses, launched the RayNeo GT Max, the first AR smart glasses supporting Dolby Vision.
  • Insta360, a leader in the action and panoramic cameras segments, launched the Luna Ultra, which supports Dolby Vision capture.
  • Google announced support for Dolby Atmos through Android Auto with partners including BMW, Genesis, Mahindra, Mercedes, Renault, and Skoda.
  • Roberts Communications Network, the largest horse racing streaming provider in the U.S., is using Dolby OptiView for ultra-low latency video streaming for horse racing.
  • Access Advance announced that Meta Platforms, Inc., one of the world's largest distributors of video content, joined the VDP program as a licensee.

Dividend

Today, Dolby announced a cash dividend of $0.36 per share of Class A and Class B common stock, payable on August 19, 2026, to stockholders of record as of the close of business on August 11, 2026.

Stock Repurchase Program

Today, Dolby also announced that its Board of Directors has approved increasing the size of its stock repurchase program by $350 million, bringing the amount available for future repurchases of its Class A Common Stock to approximately $427 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that the company considers appropriate.

Financial Outlook

Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing herein due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the third quarter of fiscal 2026, to be filed on or around the date hereof.

Dolby is providing the following estimates for its fourth quarter of fiscal 2026:

  • Total revenue is expected to range from $362 million to $392 million.
  • Licensing revenue is expected to range from $335 million to $365 million.
  • Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.
  • Operating expenses are anticipated to range from $227 million to $237 million on a GAAP basis and from $195 million to $205 million on a non-GAAP basis.
  • Effective tax rate is anticipated to be around 23% on a GAAP basis and around 21% on a non-GAAP basis.
  • Diluted earnings per share is anticipated to range from $0.78 to $0.93 on a GAAP basis and from $1.13 to $1.28 on a non-GAAP basis.

Dolby is providing the following estimates for the full year of fiscal 2026:

  • Total revenue is expected to range from $1.41 billion to $1.44 billion.
  • Licensing revenue is expected to range from $1.31 billion to $1.34 billion.
  • Gross margins are anticipated to be approximately 88% on a GAAP basis and approximately 90% on a non-GAAP basis.
  • Operating expenses are anticipated to range from $937 million to $947 million on a GAAP basis and from $785 million to $795 million on a non-GAAP basis.
  • Dolby expects operating margins to be approximately 21% on a GAAP basis and to be approximately 34% on a non-GAAP basis.
  • Effective tax rate is anticipated to be around 24% on a GAAP basis and around 21% on a non-GAAP basis.
  • Diluted earnings per share is anticipated to range from $2.62 to $2.77 on a GAAP basis and from $4.25 to $4.40 on a non-GAAP basis.

Conference Call Information

Members of Dolby management will lead a conference call open to all interested parties to discuss third quarter fiscal 2026 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, July 30, 2026.

The conference call can be accessed by registering online at Dolby Laboratories Q3 Fiscal Year 2026 Financial Results, at which time registrants will receive dial-in information as well as a conference ID.

A live audio webcast of the conference call will be available at http://investor.dolby.com where it will be archived for one year.

Non-GAAP Financial Information

To supplement Dolby's financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby's operating results in a manner that focuses on what Dolby's management believes to be its ongoing business operations and performance. We believe these non-GAAP financial measures are also helpful to investors in enabling comparability of operating performance between periods and among peer companies. Additionally, Dolby's management regularly uses our supplemental non-GAAP financial measures to make operating decisions, for planning and forecasting purposes and determining bonus payouts. Specifically, Dolby excludes the following as adjustments from one or more of its non-GAAP financial measures:

Stock-based compensation expense: Stock-based compensation, unlike cash-based compensation, utilizes subjective assumptions in the methodologies used to value the various stock-based award types that Dolby grants. These assumptions may differ from those used by other companies. To facilitate more meaningful comparisons between its underlying operating results and those of other companies, Dolby excludes stock-based compensation expense.

Amortization of acquisition-related intangibles: Dolby amortizes intangible assets acquired in connection with business combinations. These intangible assets consist of patents and technology, customer relationships, and other intangibles. Dolby records amortization charges relating to these intangible assets in its GAAP financial statements, and Dolby views these charges as items arising from pre-acquisition activities that are determined by the timing and valuation of its acquisitions. As these amortization charges do not directly correlate to its operations during any particular period, Dolby excludes these charges to facilitate an evaluation of its current operating performance and comparisons to its past operating results. In addition, while amortization expense of acquisition-related intangible assets is excluded from Non-GAAP Net Income, the revenue generated from those assets is not excluded.

Restructuring charges or credits: Restructuring charges are costs associated with restructuring plans and primarily relate to costs associated with exit or disposal activities, employee severance benefits, and asset impairments. Dolby excludes restructuring costs, including any adjustments to charges recorded in prior periods (which may be credits), as Dolby believes that these costs are not representative of its normal operating activities and therefore, excluding these amounts enables a more effective comparison of its past operating performance and to that of other companies.

Income tax adjustments: The income tax effects of the aforementioned non-GAAP adjustments do not directly correlate to its operating performance so Dolby believes that excluding such income tax effects provides a more meaningful view of its underlying operating results to management and investors.

Using the aforementioned adjustments, Dolby provides various non-GAAP financial measures including, but not limited to: non-GAAP net income, non-GAAP diluted earnings per share, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating margin, and non-GAAP effective tax rate. Dolby's management believes it is useful for itself and investors to review both GAAP and non-GAAP measures to assess the performance of Dolby's business, including

as a means to evaluate period-to-period comparisons. Dolby's management does not itself, nor does it suggest that investors should, consider non-GAAP financial measures in isolation from, superior to, or as a substitute for, financial information prepared in accordance with GAAP. Whenever Dolby uses non-GAAP financial measures, it provides a reconciliation of the non-GAAP financial measures to the most closely applicable GAAP financial measures. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed above and below. Investors are also encouraged to review Dolby's GAAP financial statements as reported in its US Securities and Exchange Commission (SEC) filings. A reconciliation between GAAP and non-GAAP financial measures is provided at the end of this press release and on the Dolby investor relations website, http://investor.dolby.com.

Forward-Looking Statements

Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the fourth quarter of fiscal 2026 and full year fiscal 2026, Dolby's ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are "forward-looking statements" that inherently involve substantial risks and uncertainties. These forward-looking statements are based on management's current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided. The following important factors, without limitation, could cause actual results to differ materially from those in the forward-looking statements: the potential impacts of economic conditions on Dolby's business operations, financial results, and financial position (including the impact to Dolby partners and disruption of the supply chain and delays in shipments of consumer products; the level at which Dolby technologies are incorporated into products and the consumer demand for such products; delays in the development and release of new products or services that contain Dolby technologies; delays in royalty reporting or delinquent payment by partners or licensees; lengthening sales cycles; the impact to the overall cinema market including adverse impact to Dolby's revenue recognized on box-office sales and demand for cinema products and services; and macroeconomic conditions that affect discretionary spending and access to products that contain Dolby technologies); risks associated with geopolitical issues and international conflicts; risks associated with trends in the markets in which Dolby operates, including the broadcast, mobile, consumer electronics, PC, and other markets; the loss of, or reduction in sales by, a key customer, partner, or licensee? pricing pressures? risks relating to changing trends in the way that content is distributed and consumed; risks relating to conducting business internationally, including trade restrictions and changes in diplomatic or trade relationships; risks relating to maintaining patent coverage? the timing of Dolby's receipt of royalty reports and payments from its licensees, including recoveries? changes in tax regulations; timing of revenue recognition under licensing agreements and other contractual arrangements? Dolby's ability to develop, maintain, and strengthen relationships with industry participants? Dolby's ability to develop and deliver innovative products and technologies in response to new and growing markets? competitive risks? risks associated with conducting business in countries that have historically limited recognition and enforcement of intellectual property and contractual rights? risks associated with the health of the motion picture and cinema industries generally? Dolby's ability to increase its revenue streams and to expand its business generally, and to continue to expand its business beyond its current technology offerings? risks associated with acquiring and successfully integrating businesses or technologies? and other risks detailed in Dolby's SEC filings and reports, including the risks identified under the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q filed on or around the date hereof. Dolby may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. Forward-looking statements are based upon information available to us as of the date of such statements, and while Dolby believes such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Except as required by law, Dolby disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

About Dolby

Dolby Laboratories (NYSE: DLB) is a world leader in immersive entertainment. From movies and TV, to music, sports, gaming, and beyond, Dolby transforms the science of sight and sound into spectacular experiences for billions of people worldwide across all their favorite devices. We partner with artists, storytellers, and the brands you love to transform entertainment and digital experiences through groundbreaking innovations like Dolby Atmos, Dolby Vision, Dolby Cinema, and Dolby OptiView.

Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby OptiView, and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain the property of their respective owners.

                                                                     
        
          DOLBY LABORATORIES, INC.
                                                             
       INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                                                 (in thousands, except per share amounts; unaudited)




                                                                                                                                      Fiscal Quarter Ended               Fis
       cal Year-To-
                                                                                                                                                                                Date Ended


                                                                                                                             June 26,                      June 27,  June 26,                    June 27,
                                                                                                                                 2026                           2025       2026                         2025



 
          Revenue:



   Licensing                                                                                                                $282,351                       $289,905   $974,367                     $966,390



   Products and services                                                                                                      22,644                         25,641     72,964                       75,716



 Total revenue                                                                                                               304,995                        315,546  1,047,331                    1,042,106





 
          Cost of revenue:



   Cost of licensing                                                                                                          22,718                         21,713     67,523                       62,508



   Cost of products and services                                                                                              17,601                         22,289     60,735                       58,105



 Total cost of revenue                                                                                                        40,319                         44,002    128,258                      120,613





 
          Gross profit                                                                                                     264,676                        271,544    919,073                      921,493





 
          Operating expenses:



   Research and development                                                                                                   65,749                         65,982    198,477                      194,327



   Sales and marketing                                                                                                        85,071                         86,163    272,786                      270,191



   General and administrative                                                                                                 75,585                         72,307    221,783                      212,814



   Restructuring charges/(credits)                                                                                             3,955                          (547)    16,605                        8,879



 Total operating expenses                                                                                                    230,360                        223,905    709,651                      686,211





 
          Operating income                                                                                                  34,316                         47,639    209,422                      235,282





 
          Other income/(expense):



   Interest income/(expense), net                                                                                              3,453                          4,111     12,595                       10,316



   Other income, net                                                                                                           6,033                          3,766     13,086                       16,219



 Total other income                                                                                                            9,486                          7,877     25,681                       26,535





 Income before income taxes                                                                                                   43,802                         55,516    235,103                      261,817



  Provision for income taxes                                                                                                (14,588)                       (8,974)  (56,754)                    (54,979)



 Net income including noncontrolling interest                                                                                 29,214                         46,542    178,349                      206,838



  Less: net income attributable to noncontrolling interest                                                                     (612)                         (471)   (1,505)                     (1,152)



 
          Net income attributable to Dolby Laboratories, Inc.                                                              $28,602                        $46,071   $176,844                     $205,686





 Net income per share:



 Basic                                                                                                                         $0.30                          $0.48      $1.86                        $2.14



 Diluted                                                                                                                       $0.30                          $0.48      $1.84                        $2.11



 Weighted-average shares outstanding:



 Basic                                                                                                                        94,242                         95,897     94,975                       95,947



 Diluted                                                                                                                      94,518                         96,900     95,859                       97,537

                                    
          
            DOLBY LABORATORIES, INC.
                               
            INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
                                                (in thousands; unaudited)




                                                                                            June 26, September 26,
                                                                                                2026           2025



 
            ASSETS



 Current assets:



  Cash and cash equivalents                                                                $669,394       $701,893



  Restricted cash                                                                            69,492         91,468



  Short-term investments                                                                        652            703



  Accounts receivable, net                                                                  285,148        331,096



  Contract assets, net                                                                      206,881        180,804



  Inventories, net                                                                           30,768         30,424



  Prepaid expenses and other current assets                                                  63,706         51,873



 Total current assets                                                                     1,326,041      1,388,261



  Long-term investments                                                                      86,437         80,205



  Property, plant, and equipment, net                                                       459,115        470,608



  Operating lease right-of-use assets                                                        42,401         33,204



  Goodwill and intangible assets, net                                                       910,777        926,957



  Deferred taxes                                                                            213,171        214,361



  Other non-current assets                                                                  118,660        114,164



 
            Total assets                                                               $3,156,602     $3,227,760





 
            LIABILITIES AND STOCKHOLDERS' EQUITY



 Current liabilities:



  Accounts payable                                                                          $12,470        $17,840



  Accrued liabilities                                                                       360,407        369,256



  Income taxes payable                                                                            -         8,928



  Contract liabilities                                                                       33,593         31,382



  Operating lease liabilities                                                                 9,859         10,384



 Total current liabilities                                                                  416,329        437,790



  Non-current contract liabilities                                                           23,463         29,687



  Non-current operating lease liabilities                                                    37,591         28,494



  Other non-current liabilities                                                              86,504         99,843



 Total liabilities                                                                          563,887        595,814





 Stockholders' equity:



  Class A common stock                                                                           52             54



  Class B common stock                                                                           40             40



  Retained earnings                                                                       2,598,923      2,634,980



  Accumulated other comprehensive loss                                                     (15,468)      (12,517)



 Total stockholders' equity - Dolby Laboratories, Inc.                                    2,583,547      2,622,557



  Noncontrolling interest                                                                     9,168          9,389



 Total stockholders' equity                                                               2,592,715      2,631,946



 
            Total liabilities and stockholders' equity                                 $3,156,602     $3,227,760

                                                                               
          
            DOLBY LABORATORIES, INC.
                                                                     
            INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                                                          (in thousands; unaudited)




                                                                                                                                                   Fiscal Year-To-Date Ended


                                                                                                                                           June 26,                           June 27,
                                                                                                                                               2026                                2025



 
            Operating activities:



 Net income including noncontrolling interest                                                                                             $178,349                            $206,838



 Adjustments to reconcile net income to net cash provided by operating activities:



   Depreciation and amortization                                                                                                            70,842                              65,829



   Stock-based compensation                                                                                                                 98,883                              97,462



   Amortization of operating lease right-of-use assets                                                                                       7,889                               8,193



   Provision for credit losses                                                                                                               4,244                               2,582



   Deferred income taxes                                                                                                                     1,542                             (9,146)



   Share of net income of equity method investees, net of cash distributions                                                               (7,602)                              1,845



   Other non-cash items affecting net income                                                                                               (1,289)                              (429)



   Changes in operating assets and liabilities:



  Accounts receivable, net                                                                                                                   1,489                              15,234



  Contract assets, net                                                                                                                    (28,442)                            (6,902)



  Inventories                                                                                                                                6,512                               4,020



  Operating lease right-of-use assets                                                                                                     (17,547)                            (1,717)



  Prepaid expenses and other assets                                                                                                       (31,999)                             28,003



  Accounts payable and accrued liabilities                                                                                                  35,611                            (48,979)



  Income taxes, net                                                                                                                        (2,771)                              1,895



  Contract liabilities                                                                                                                       1,620                             (1,061)



  Operating lease liabilities                                                                                                                9,036                             (8,237)



  Other non-current liabilities                                                                                                           (11,600)                            (6,063)



 Net cash provided by operating activities                                                                                                 314,767                             349,367





 
            Investing activities:



  Proceeds from sales of marketable securities                                                                                                   -                             15,911



  Proceeds from sale of assets held for sale                                                                                                     -                             16,881



  Purchases of property, plant, and equipment                                                                                             (28,681)                           (20,104)



  Business combinations, net of cash and restricted cash acquired, and other related payments                                                    -                            (1,362)



  Purchases of intangible assets                                                                                                          (42,575)



  Proceeds from sale of intangible assets                                                                                                   16,623



 Net cash provided by/(used in) investing activities                                                                                      (54,633)                             11,326





 
            Financing activities:



  Proceeds from issuance of common stock                                                                                                    24,685                              38,681



  Repurchase of common stock                                                                                                             (200,001)                           (89,990)



  Payment of excise tax on repurchase of common stock                                                                                            -                              (261)



  Payment of cash dividend                                                                                                               (102,659)                           (95,010)



  Distributions to noncontrolling interest                                                                                                 (1,640)                            (1,449)



  Shares repurchased for tax withholdings on vesting of restricted stock                                                                  (33,113)                           (35,154)



 Net cash used in financing activities                                                                                                   (312,728)                          (183,183)





  Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash                                                   (1,881)                              1,302



 Net increase/(decrease) in cash, cash equivalents, and restricted cash                                                                   (54,475)                            178,812



 Cash, cash equivalents, and restricted cash at beginning of period                                                                        793,361                             577,752



 Cash, cash equivalents, and restricted cash at end of period                                                                             $738,886                            $756,564

                                                          
          
            Licensing Revenue by Market
                                                                        
            (unaudited)





          The following table presents the composition of our licensing revenue and percentage of total licensing revenue for all periods presented (in thousands,
except percentage amounts):




                                                                     
          
            Fiscal Quarter Ended                                  Fiscal Year-To-Date Ended



          
            
              Market                                              June 26, 2026                                 June 27, 2025                              June 26, 2026 June 27, 2025



          Broadcast                                                    $106,579       38 %              $111,286       38 %              $326,041       33 %              $321,297    33 %



          Mobile                                                         51,010       18 %                56,295       19 %               220,199       23 %               217,942    23 %



          CE                                                             31,506       11 %                28,071       10 %               118,057       12 %               115,668    12 %



          PC                                                             28,343       10 %                33,589       12 %               116,523       12 %               123,247    13 %



          Other                                                          64,913       23 %                60,664       21 %               193,547       20 %               188,236    19 %



          
            Total licensing revenue                         $282,351      100 %              $289,905      100 %              $974,367      100 %              $966,390   100 %



                                                                                            
          
            GAAP to Non-GAAP Reconciliations


                                                                                                      
          
            (unaudited)





          The following tables present Dolby's GAAP financial measures reconciled to the non-GAAP financial measures included in this release for the third
 quarters of fiscal 2026 and fiscal 2025:





          
            Net income:                                                                                                                                   Fiscal Quarter Ended



          
            (in thousands)                                                                                                                       June 26,                      June 27,
                                                                                                                                                                 2026                           2025



          GAAP net income attributable to Dolby Laboratories, Inc.                                                                                           $28,602                        $46,071



          Stock-based compensation (1)                                                                                                                        30,964                         30,728



          Amortization of acquisition-related intangibles (2)                                                                                                  9,705                         10,016



          Restructuring charges/(credits)                                                                                                                      3,955                          (547)



          Income tax adjustments                                                                                                                             (8,077)                      (10,606)



          Non-GAAP net income attributable to Dolby Laboratories, Inc.                                                                                       $65,149                        $75,662





          (1) Stock-based compensation included in above line items:



            Cost of products and services                                                                                                                       $440                           $420



            Research and development                                                                                                                           9,695                          9,188



            Sales and marketing                                                                                                                               10,293                         10,589



            General and administrative                                                                                                                        10,536                         10,531





          (2) Amortization of acquisition-related intangibles included in above line items:



            Cost of licensing                                                                                                                                 $6,590                         $6,610



            Cost of products and services                                                                                                                        768                            753



            Sales and marketing                                                                                                                                  352                            340



            General and administrative                                                                                                                         1,554                          1,872



            Other income, net                                                                                                                                    441                            441





          
            Diluted earnings per share:                                                                                                                   Fiscal Quarter Ended


                                                                                                                                                             June 26,                      June 27,
                                                                                                                                                                 2026                           2025



          GAAP diluted earnings per share                                                                                                                      $0.30                          $0.48



          Stock-based compensation                                                                                                                              0.33                           0.32



          Amortization of acquisition-related intangibles                                                                                                       0.10                           0.10



          Restructuring charges/(credits)                                                                                                                       0.04                         (0.01)



          Income tax adjustments                                                                                                                              (0.08)                        (0.11)



          Non-GAAP diluted earnings per share                                                                                                                  $0.69                          $0.78





          Weighted-average shares outstanding - diluted (in thousands)                                                                                        94,518                         96,900




          The following tables present a reconciliation between GAAP and non-GAAP versions of the estimated financial measures for the fourth quarter of
fiscal 2026 and full year fiscal 2026 included in this release:





          
            Gross margin:                                                                                                                                        Q4 2026                         Fiscal 2026



          GAAP gross margin                                                                                                                                                  88.0 %                              88.0 %



          Stock-based compensation                                                                                                                                            0.1 %                               0.1 %



          Amortization of acquisition-related intangibles                                                                                                                     1.9 %                               1.9 %



          Non-GAAP gross margin                                                                                                                                              90.0 %                              90.0 %





          
            Operating expenses 
            
              (in millions)
            
            :                                                              Q4 2026                         Fiscal 2026



          GAAP operating expenses (low - high end of range)                                                                                                      
      $227 - $237                  
      $937 - $947



          Stock-based compensation                                                                                                                                             (30)                               (127)



          Amortization of acquisition-related intangibles                                                                                                                       (2)                                 (8)



          Restructuring charges                                                                                                                                                                                    (17)



          Non-GAAP operating expenses (low - high end of range)                                                                                                  
      $195 - $205                  
      $785 - $795





          
            Operating margin:                                                                                                                                                                  Fiscal 2026



          GAAP operating margin                                                                                                                                                                                 21% +/-



          Stock-based compensation                                                                                                                                                                                  9 %



          Amortization of acquisition-related intangibles                                                                                                                                                           3 %



          Restructuring charges                                                                                                                                                                                     1 %



          Non-GAAP operating margin                                                                                                                                                                             34% +/-





          
            Effective tax rate:                                                                                                                                  Q4 2026                         Fiscal 2026



          GAAP effective tax rate                                                                                                                                            23.0 %                              24.0 %



          Stock-based compensation (low - high end of range)                                                                                                              (2%) - 1%                          (2%) - 0%



          Amortization of acquisition-related intangibles (low - high end of                                                                                              (1%) - 0%                          (1%) - 0%
range)



          Non-GAAP effective tax rate                                                                                                                                        21.0 %                              21.0 %





          
            Diluted earnings per share:                                                                                                              Q4 2026                       Fiscal 2026


                                                                                                                                                             Low               High      Low                     High



          GAAP diluted earnings per share (low - high end of range)                                                                                       $0.78                $0.93    $2.62                        $2.77



          Stock-based compensation  (low - high end of range)                                                                                              0.32                 0.32     1.33                         1.33



          Amortization of acquisition-related intangibles (low - high end of                                                                               0.10                 0.10     0.41                         0.41
range)



          Restructuring charges (low - high end of range)                                                                                                                              0.18                         0.18



          Income tax adjustments (low - high end of range)                                                                                               (0.07)              (0.07)  (0.29)                      (0.29)



          Non-GAAP diluted earnings per share (low - high end of range)                                                                                   $1.13                $1.28    $4.25                        $4.40





          Weighted-average shares outstanding - diluted (in thousands)                                                                                   93,600               93,600   95,200                       95,200

Investor Contact:
Peter Goldmacher
415-254-7415
peter.goldmacher@dolby.com

Media Contact:
media@dolby.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-third-quarter-2026-financial-results-302839283.html

SOURCE Dolby Laboratories, Inc.

© 2026 Canjex Publishing Ltd. All rights reserved.